United Services Automobile Association increased its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 7.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,534 shares of the medical technology company’s stock after buying an additional 1,544 shares during the period. United Services Automobile Association’s holdings in Hill-Rom were worth $1,881,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in HRC. Advisors Asset Management Inc. boosted its holdings in Hill-Rom by 557.8% in the 2nd quarter. Advisors Asset Management Inc. now owns 6,749 shares of the medical technology company’s stock valued at $589,000 after purchasing an additional 5,723 shares during the period. WINTON GROUP Ltd boosted its holdings in Hill-Rom by 488.4% in the 2nd quarter. WINTON GROUP Ltd now owns 108,252 shares of the medical technology company’s stock valued at $9,455,000 after purchasing an additional 89,855 shares during the period. Verition Fund Management LLC bought a new position in Hill-Rom in the 2nd quarter valued at $1,081,000. California Public Employees Retirement System boosted its holdings in Hill-Rom by 3.2% in the 2nd quarter. California Public Employees Retirement System now owns 177,972 shares of the medical technology company’s stock valued at $15,544,000 after purchasing an additional 5,501 shares during the period. Finally, Putnam Investments LLC bought a new position in Hill-Rom in the 2nd quarter valued at $3,201,000. 81.20% of the stock is owned by institutional investors.
Hill-Rom stock opened at $87.30 on Friday. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.18 and a current ratio of 1.58. The firm has a market cap of $5.88 billion, a PE ratio of 19.94, a P/E/G ratio of 1.25 and a beta of 0.89. Hill-Rom Holdings, Inc. has a fifty-two week low of $75.21 and a fifty-two week high of $98.96.
Several brokerages have commented on HRC. Barclays began coverage on shares of Hill-Rom in a report on Monday, October 15th. They issued an “equal weight” rating and a $95.00 price target for the company. Morgan Stanley raised their price target on shares of Hill-Rom from $95.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, October 11th. ValuEngine downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a report on Thursday, October 4th. Zacks Investment Research downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a report on Wednesday, August 1st. Finally, Northcoast Research reissued a “buy” rating and issued a $104.00 price target on shares of Hill-Rom in a report on Tuesday, July 31st. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Hill-Rom has a consensus rating of “Hold” and an average target price of $99.44.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Story: Cash Flow
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.